-
Something wrong with this record ?
Quantitative analysis of drug losses administered via nasogastric tube--In vitro study
A. Ruzsíková, L. Součková, P. Suk, R. Opatřilová, M. Kejdušová, V. Šrámek,
Language English Country Netherlands
Document type Journal Article
- MeSH
- Intubation, Gastrointestinal * MeSH
- Pharmaceutical Preparations administration & dosage chemistry MeSH
- Delayed-Action Preparations administration & dosage chemistry MeSH
- Tablets administration & dosage chemistry MeSH
- Capsules administration & dosage chemistry MeSH
- Publication type
- Journal Article MeSH
PURPOSE: Drug administration through nasogastric tube (NGT) is a standard practice but the real amount of the delivered drug is unknown. Therefore, we designed a study to determine the losses of various dosage forms administered by different methods through NGT. METHODS: In vitro model was used. Five different administration methods (A-E) and six dosage forms (simple compressed tablets - T/S; film coated tablets - T/FC; enteric coated tablets - T/EC; capsules with powder filling - C/P; capsules containing extended release pellets - C/ER; capsules containing gastro-resistant pellets - C/GR) were investigated. Measurement was repeated six times for each drug-method combination. The overall losses were determined by gravimetry. In method A partial losses associated with each step of drug administration were also determined. RESULTS: Significant drug losses were measured (4-38%). Only methods A (crushing-beaker-syringe-water-NGT) and B (crushing-water-syringe-NGT) were suitable for administration of all tested dosage forms. Method B proved the most effective for all kinds of tablets and C/GR (p<0.05) and tended to be more effective also for C/ER (p=0.052) compared to method A. C/P showed minimal losses for both tested methods (B and E). Flushing of the drug through NGT causes major losses during drug administration compared to crushing and transfer (p<0.05). All methods for intact pellets (C-E) were found inappropriate for clinical practice due to NGT clogging. CONCLUSIONS: Choosing a suitable administration method can significantly affect the amount of drugs delivered through NGT.
Faculty of Medicine Masaryk University Brno Czech Republic
Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences Brno Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16028516
- 003
- CZ-PrNML
- 005
- 20161024110145.0
- 007
- ta
- 008
- 161005s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2014.11.065 $2 doi
- 024 7_
- $a 10.1016/j.ijpharm.2014.11.065 $2 doi
- 035 __
- $a (PubMed)25437112
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Ruzsíková, Adriana $u Department of Anaesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 245 10
- $a Quantitative analysis of drug losses administered via nasogastric tube--In vitro study / $c A. Ruzsíková, L. Součková, P. Suk, R. Opatřilová, M. Kejdušová, V. Šrámek,
- 520 9_
- $a PURPOSE: Drug administration through nasogastric tube (NGT) is a standard practice but the real amount of the delivered drug is unknown. Therefore, we designed a study to determine the losses of various dosage forms administered by different methods through NGT. METHODS: In vitro model was used. Five different administration methods (A-E) and six dosage forms (simple compressed tablets - T/S; film coated tablets - T/FC; enteric coated tablets - T/EC; capsules with powder filling - C/P; capsules containing extended release pellets - C/ER; capsules containing gastro-resistant pellets - C/GR) were investigated. Measurement was repeated six times for each drug-method combination. The overall losses were determined by gravimetry. In method A partial losses associated with each step of drug administration were also determined. RESULTS: Significant drug losses were measured (4-38%). Only methods A (crushing-beaker-syringe-water-NGT) and B (crushing-water-syringe-NGT) were suitable for administration of all tested dosage forms. Method B proved the most effective for all kinds of tablets and C/GR (p<0.05) and tended to be more effective also for C/ER (p=0.052) compared to method A. C/P showed minimal losses for both tested methods (B and E). Flushing of the drug through NGT causes major losses during drug administration compared to crushing and transfer (p<0.05). All methods for intact pellets (C-E) were found inappropriate for clinical practice due to NGT clogging. CONCLUSIONS: Choosing a suitable administration method can significantly affect the amount of drugs delivered through NGT.
- 650 _2
- $a tobolky $x aplikace a dávkování $x chemie $7 D002214
- 650 _2
- $a léky s prodlouženým účinkem $x aplikace a dávkování $x chemie $7 D003692
- 650 12
- $a gastrointestinální intubace $7 D007441
- 650 _2
- $a léčivé přípravky $x aplikace a dávkování $x chemie $7 D004364
- 650 _2
- $a tablety $x aplikace a dávkování $x chemie $7 D013607
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Součková, Lenka $u Department of Anaesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Suk, Pavel $u Department of Anaesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Opatřilová, Radka $u Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
- 700 1_
- $a Kejdušová, Martina $u Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
- 700 1_
- $a Šrámek, Vladimír $u Department of Anaesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: vladimir.sramek@fnusa.cz.
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 478, č. 1 (2015), s. 368-71
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25437112 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20161024110558 $b ABA008
- 999 __
- $a ok $b bmc $g 1166830 $s 953146
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 478 $c 1 $d 368-71 $e 20141128 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20161005